← Scroll for more →
enGene Therapeutics Inc. (ENGNW)
Biological Products, (No Diagnostic Substances)
Latest Price
$0.18
TTM P/E
0.67
Normalized P/E
0.00
TTM Div Yield
--
Fwd Div Yield
--
Book Value
3.44
P/B Ratio
0.05
Valuation metrics
adjust assumptions →EPS: $2.29
Book value / share: $3.22
Formula: √(22.5 × EPS × BVPS)
Graham Number
$12.89
+7009% upside
Institutional Ownership
3.8% held by institutions| Institution | Shares | Value | Ownership % | Change | Filing Date |
|---|---|---|---|---|---|
| Bvf Inc | 945.4K | -- | 1.41% | -- | 2026-06-30 |
| Blue Owl Capital Holdings LP | 511.2K | -- | 0.76% | -- | 2026-06-30 |
| Caption Management, LLC | 333.7K | -- | 0.50% | -- | 2026-06-30 |
| LMR Partners LLP | 309.8K | -- | 0.46% | -- | 2026-06-30 |
| Aristeia Capital, L.L.C. | 197.7K | -- | 0.29% | -- | 2026-06-30 |
| D. E. Shaw & Co., Inc. | 104.6K | -- | 0.16% | -- | 2026-06-30 |
| Millennium Management LLC | 69.0K | -- | 0.10% | -- | 2026-06-30 |
| Toronto Dominion Bank | 31.5K | -- | 0.05% | -- | 2026-06-30 |
| Css LLC | 16.9K | -- | 0.03% | -- | 2026-06-30 |
| StoneX Group Inc. | 10.4K | -- | 0.02% | -- | 2026-06-30 |